Elevations in transferrin saturation and serum iron in OCP users have previously been suggested to be due to hepatic effects of exogenous estrogens (McKnight et al., 1980), with OCP users more likely to have transferrin saturation levels >45% and be considered at risk of hemochromatosis (McKnight et al., 1980). This evidence concerns the gene TF and hemochromatosis type 1.